Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2025-12-24 @ 10:12 PM
NCT ID:
NCT03208335
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed hepatocellular carcinoma,or radiographic indicative HCC with AFP\>250ug/l
* Inoperable and untransplantable,Child-pugh score A or B
* PS score 0-1
* At least one measurable site(diameter \>20mm measured by CT or MRI,\>10mm measured by helical CT scan.
* No distant metastases
* Life expectancy longer than 3 months
* Willingness and ability to comply the study and signed informed consent.
Exclusion Criteria:
* Not comply the designed treatment or change to other treatment
* Miss follow-up visits or have incomplete follow-up data
* The efficacy will not be assessed if the Patient withdrawal the treatment due to severe adverse events(SAE),but SAE will be recorded.
* Disease progression
* Patients request to withdraw
* Patients with III hematologic or Ⅳ nonhematologic drug related toxicity ,or SAE
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03208335
Study Brief:
Protocol Section:
NCT03208335